In The Field

AHA 2008: Should statins be put in the water?

The biggest story to come out of the American Heart Association’s annual jamboree is undoubtedly the JUPITER randomised controlled trial, which was showcased on Monday to a packed auditorium of over 6000 cardiologists. Data from the trial suggest that even healthy people with low cholesterol may benefit from receiving rosuvastatin to prevent cardiac events, if they have high levels of high-sensitivity C-reactive protein. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE